ClearNote Health
PrivateLast Round
Series D
May 27, 2026
Total Funding Raised
$143.8M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
ClearNote Health operates in Healthcare & Life Sciences and is based in San Diego, California. Its latest recorded funding round was a Series D round in May 2026.
ClearNote Health is a biotechnology company that develops non-invasive blood tests to detect high-mortality cancers at an early stage.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ClearNote Health Comparables
Compare ClearNote Health with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Adela | 82% | |
| Singlera Genomics Inc. | 82% | |
| Mercy BioAnalytics | 82% |
For institutional investors. Book with your work email.
ClearNote Health Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | May 27, 2026 | ||||
| Series D | Jun 5, 2025 | ||||
| Series C | May 12, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
ClearNote Health Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Prosperity Capital Management | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 27, 2026
$52M round led by Mattias Westman
- Sep 18, 2025
Partnered with BCAL Diagnostics Limited to integrate diagnostic technology.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventSep 16, 2026
ClearNote Health presents new data on its Avantect Pancreatic Cancer Test and Virtuoso platform at the AACR Conference on Pancreatic Cancer to showcase the power of 5hmc signatures for treatment monitoring.
For institutional investors. Book with your work email.
ClearNote Health Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ClearNote Health's valuation, stock price, and market status.
Is ClearNote Health a public or private company?
ClearNote Health is a private company.
What is the current stock price of ClearNote Health?
ClearNote Health is a private company, so its shares have no public market price. Caplight tracks ClearNote Health's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ClearNote Health worth (valuation)?
Valuation information for ClearNote Health is not publicly available.
Can I buy ClearNote Health stock?
ClearNote Health shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ClearNote Health's last funding round?
ClearNote Health's most recent funding round was Series D on May 27, 2026.
Who are the main investors in ClearNote Health?
Key investors in ClearNote Health include Prosperity Capital Management.
Will ClearNote Health IPO soon?
No public IPO plans have been announced for ClearNote Health.
How can I track ClearNote Health secondary market activity?
Caplight tracks bids, offers, and trades in ClearNote Health's shares on secondary markets.